Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation (Q45066546)
Jump to navigation
Jump to search
scientific article published on 30 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation |
scientific article published on 30 July 2014 |
Statements
1 reference
Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation (English)
1 reference
J Gregory Cairncross
1 reference
Stephanie A Nguyen
1 reference
Owen D M Stechishin
1 reference
H Artee Luchman
1 reference
Xueqing Q Lun
1 reference
Donna L Senger
1 reference
Stephen M Robbins
1 reference
Samuel Weiss
1 reference
30 July 2014
1 reference
1 reference
20
1 reference
18
1 reference
4894-4903
1 reference
Identifiers
1 reference
1 reference